Castle Biosciences announced that it will share new data across its dermatologic portfolio of gene expression profile, GEP, tests at the 2023 Fall Clinical Dermatology Conference, FC23, taking place Oct. 19-22, 2023, in Las Vegas. “The breadth of data we are sharing at Fall Clinical reinforces our commitment to improving the care of patients with skin cancers and inflammatory skin conditions through innovative tests that can guide more informed disease management decisions,” said Derek Maetzold, president and chief executive officer of Castle Biosciences.
Confident Investing Starts Here:
- Easily unpack a company's performance with TipRanks' new KPI Data for smart investment decisions
- Receive undervalued, market resilient stocks right to your inbox with TipRanks' Smart Value Newsletter
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
See today’s best-performing stocks on TipRanks >>
Read More on CSTL:
- Castle Biosciences management to meet virtually with Stephens
- Castle Biosciences announces publication of TissueCypher test data
- Castle Biosciences gets ‘NY Laboratory Permit’ for Pittsburgh facility
- Castle Biosciences management to meet with KeyBanc
Looking for a trading platform? Check out TipRanks' Best Online Brokers , and find the ideal broker for your trades.
Report an Issue